ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Sign Up

Already a member? Sign in

Pepperstone

Trade Now

Pepperstone
Market Data
News
Trading Tools
Markets
Discover

Hot Features

Follow Feed

Connect with traders and investors in our Follow Feed community.

Options Flow

Explore comprehensive options data and use advanced filters with Options Flow.

Monitor

Organize and monitor your stock and asset watchlist with Monitor.
AI Sign In Premium IconPremium Help Menu
S&P ASX 200
7,971.60
-0.81%
S&P ASX All Technology
3,098.20
-0.24%
Brent Oil
81.875
0.00%
US Dollar vs AUD
1.49589
-0.01%
Bitcoin
66,753.93
-0.62%
Registration Strip Icon for pro Trade like a pro: Leverage real-time discussions and market-moving ideas to outperform.
Get Started
  1. Home
  2. Investing
  3. Stocks
  4. USA
  5. NYSE
  6. Eli Lilly and Co (LLY)

  7. Eli Lilly and Co (LLY) News

LLY

Eli Lilly (LLY)

Eli Lilly and Co
Date:
Sort by:
 Showing the most relevant articles for your search:NYSE:LLY
DateTimeSourceHeadlineSymbolCompany
20/07/202406:16Edgar (US Regulatory)Form 3 - Initial statement of beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/07/202420:09Edgar (US Regulatory)Form SC TO-T - Tender offer statement by Third PartyNYSE:LLYEli Lilly and Co
17/07/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
17/07/202406:21Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
17/07/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
17/07/202406:18Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
17/07/202406:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
12/07/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
11/07/202403:19Edgar (US Regulatory)Form 144 - Report of proposed sale of securitiesNYSE:LLYEli Lilly and Co
10/07/202422:40Edgar (US Regulatory)Form 8-K - Current reportNYSE:LLYEli Lilly and Co
10/07/202420:42IH Market NewsMicrosoft and Apple Exit OpenAI Board, TSMC Exceeds Forecasts with Record Revenue, and Other Key UpdatesNYSE:LLYEli Lilly and Co
10/07/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
09/07/202420:54IH Market NewsBP Slashes Profit Forecast by $700 Million; Morgan Stanley Predicts S&P 500 10% Drop, and More NewsNYSE:LLYEli Lilly and Co
09/07/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
08/07/202421:14Edgar (US Regulatory)Form SC TO-C - Written communication relating to an issuer or third partyNYSE:LLYEli Lilly and Co
08/07/202420:45PR Newswire (US)Lilly to Acquire Morphic to Improve Outcomes for Patients with Inflammatory Bowel DiseaseNYSE:LLYEli Lilly and Co
08/07/202420:37IH Market NewsParamount-Skydance $28B Merger, Boeing Agrees to Plead Guilty with $243.6M Fine, and More NewsNYSE:LLYEli Lilly and Co
03/07/202420:59IH Market NewsApple Joins OpenAI Board, Logitech President Opts Out of Reelection, and More NewsNYSE:LLYEli Lilly and Co
03/07/202403:35PR Newswire (US)Lilly's Kisunla™ (donanemab-azbt) Approved by the FDA for the Treatment of Early Symptomatic Alzheimer's DiseaseNYSE:LLYEli Lilly and Co
26/06/202400:00PR Newswire (US)Lilly collaborates with OpenAI to discover novel medicines to treat drug-resistant bacteriaNYSE:LLYEli Lilly and Co
25/06/202401:30PR Newswire (US)Lilly Declares Third-Quarter 2024 DividendNYSE:LLYEli Lilly and Co
24/06/202421:00IH Market NewsUPS Divests Coyote Logistics in $1.025 Billion Deal with RXO, Under Armour Agrees to $434 million Settlement, and More NewsNYSE:LLYEli Lilly and Co
22/06/202405:49PR Newswire (US)Lilly's tirzepatide reduced obstructive sleep apnea (OSA) severity, with up to 51.5% of participants meeting the criteria for disease resolutionNYSE:LLYEli Lilly and Co
19/06/202406:23Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:22Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:20Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:19Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:17Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
19/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
18/06/202406:00Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNYSE:LLYEli Lilly and Co
 Showing the most relevant articles for your search:NYSE:LLY

Your Recent History

ASX
FMG
Fortescue
FX
AUDJPY
AUD vs Yen
ASX
NAB
National Australia Bank
ASX
MQG
Macquarie
ASX
CBA
Commonwealth Bank Of Aus...
ASX
XAO
Australian SE All Ordina...
CCOM
SILVER
SILVER
COIN
BTCUSD
Bitcoin
ASX
QBE
QBE Insurance
NYSE
MCD
McDonalds
NASDAQ
NVDA
NVIDIA
COIN
ETHUSD
Ethereum
ASX
CSL
CSL
ASX
WDC
Westfield
FX
AUDUSD
AUD vs US Dollar
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

Australia
Company
Business
Popular
Get The App
App Store
Google Play

Support: +44 (0) 203 8794 460 | support@advfn.com

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

© 2024 ADVFN PLC - All Rights Reserved